Registration number: 10373052

BSN (SW) Limited

Contents

Balance Sheet	1 to 2
Notes to the Unaudited Financial Statements	3 to 9

BSN (SW) Limited

(Registration number: 10373052)
Balance Sheet as at 31 January 2026

	Note	2026 £	2025 £
Fixed assets
Intangible assets	4	8,400	8,400
Tangible assets	5	200,114	165,052
		208,514	173,452
Current assets
Stocks	6	91,042	59,229
Debtors	7	558,425	335,362
Cash at bank and in hand		547,464	155,006
		1,196,931	549,597
Creditors: Amounts falling due within one year	8	(1,022,624)	(306,784)
Net current assets		174,307	242,813
Total assets less current liabilities		382,821	416,265
Creditors: Amounts falling due after more than one year	8	(79,500)	(148,823)
Provisions for liabilities		(10,589)	(4,127)
Net assets		292,732	263,315
Capital and reserves
Called up share capital		100	100
Retained earnings		292,632	263,215
Shareholders' funds		292,732	263,315

BSN (SW) Limited

(Registration number: 10373052)
Balance Sheet as at 31 January 2026

For the financial year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 14 October 2026 and signed on its behalf by:
 

Mr W A Lang Director

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2026

1	General information

The company is a private company limited by share capital, incorporated in England and Wales..

The address of its registered office is:
10 Mulberry Court
Lustleigh Close
Matford Business Park
Exeter
Devon
EX2 8PW

These financial statements were authorised for issue by the Board on 14 October 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling, which is the functional and presentational currency of the company, and rounded to the nearest £.

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2026

Key sources of estimation uncertainty

In the application of the company's accounting policies the director(s) are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of revision and future periods if the revision affects both current and future periods.

Revenue recognition

Turnover represents amounts chargeable in respect of the sale of goods and services net of value added tax.

Goods sold are recognised upon the completion of the transaction on the delivery of the goods.

Hire sales are recognised straight line over the term of the lease agreements.
 

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the Balance Sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Office equipment	25% straight line
Motor vehicles	25% reducing balance

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2026

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Intangible assets

Other Intangibles assets are recognised initially at cost which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through the profit and loss when they can otherwise be measured reliably.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Other investments	Remeasured to fair value at each reporting date
Other intangible assets	Not amortised as the residual value exceeds the cost.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year was 2 (2025 - 2).

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2026

4	Intangible assets

	Other intangible assets  £	Total £
Cost or valuation
At 1 February 2025	8,400	8,400
At 31 January 2026	8,400	8,400
Amortisation
Carrying amount
At 31 January 2026	8,400	8,400
At 31 January 2025	8,400	8,400

The director has assessed the valuation of the other investments and considers that the market value as at 31 January 2026 is £nil (2025: £nil)

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2026

5	Tangible assets

	Office equipment £	Motor vehicles  £	Total £
Cost or valuation
At 1 February 2025	6,773	297,087	303,860
Additions	4,891	104,435	109,326
Disposals	-	(17,750)	(17,750)
At 31 January 2026	11,664	383,772	395,436
Depreciation
At 1 February 2025	4,851	133,957	138,808
Charge for the year	2,810	65,370	68,180
Eliminated on disposal	-	(11,666)	(11,666)
At 31 January 2026	7,661	187,661	195,322
Carrying amount
At 31 January 2026	4,003	196,111	200,114
At 31 January 2025	1,922	163,130	165,052

6

Stocks

	2026 £	2025 £
Other inventories	91,042	59,229

7

Debtors

	2026 £	2025 £
Trade debtors	182,674	65,638
Other debtors	375,751	269,724
	558,425	335,362

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2026

8

Creditors

Due within one year	Note	2026 £	2025 £
Loans and borrowings	9	104,675	85,006
Trade creditors		529,370	121,362
Social security and other taxes		26,446	23,598
Other creditors		-	1,045
Accruals		143,168	48,185
Corporation tax liability		31,387	27,588
Deferred income		187,578	-
		1,022,624	306,784
Due after one year
Loans and borrowings	9	79,500	148,823